Canadian Cannabis LP
Tier 2 Index
The Canadian Cannabis LP Tier 2 Index represents the publicly-traded market for companies that are currently generating quarterly sales of $5-25 million.
The Canadian Cannabis LP Tier 2 index is equal-weighted at the time of the month-end rebalancing and includes includes members of the Canadian Cannabis LP Index with quarterly revenue tied to cannabis sales between $5 million and $25 million. The index is based upon information available as of 02/24/21. We raised the maximum to $25 million as of 12/31/20. From 12/31-18 to 6/30/20, the range for Tier 2 was $2.5-10 million. For 2018 and earlier, the Tier 2 index included all LPs licensed to sell but with quarterly revenue below $4 million.
Inclusion in the index is not an endorsement or recommendation of any company. The companies included are designed to represent the overall market for the medical and legal marijuana sector. To summarize, it includes both the good and the bad. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. QuoteMedia Data delayed 15 minutes unless otherwise indicated.